(Q39628692)
Statements
Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC (English)
Maeva Dufies
Mickaël Ohanna
Marcel Deckert
Jean-Max Pasquet
François-Xavier Mahon
Jill-Patrice Cassuto
Sophie Raynaud
23 November 2010